Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shahad Alanazi"'
Autor:
Hatan Mortada, Nawaf Alhindi, Abdulrahman Abukhudair, Shahad Alanazi, Alaa AlSahli, Khalid Arab
Publikováno v:
JPRAS Open, Vol 35, Iss , Pp 6-17 (2023)
Glutamine (GLN) has been proven to improve the prognosis of severely burned patients. GLN supplementation in critical illness has gained extreme popularity among researchers over the years, and its safety and efficacy are still under question. Theref
Externí odkaz:
https://doaj.org/article/f4ae9beef8934cec90445ebdd075fda1
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Awatif Hafiz, Mai Alalawi, Hisham A. Badreldin, Ali F. Altebainawi, Ramesh Vishwakarma, Abdulrahman Alissa, Albandari Alghamdi, Abeer A. Alenazi, Huda Al Enazi, Shahad Alanazi, Abdullah Alhammad, Jahad Alghamdi, Mashael AlFaifi, Faisal A. Al Sehli, Maram A. Aldossari, Alaa A. Alhubaishi, Anfal Y. Al-Ali, Hasan M. Al-Dorzi
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Thrombotic events are common in critically ill patients with COVID-19 and have been linked with COVID-19- induced hyperinflammatory state. In addition to anticoagulant effects, heparin and its derivatives have various anti-inflamm
Externí odkaz:
https://doaj.org/article/7767b9f73d1f4814aafcb7e17bec2b95
Autor:
Difallah Alenezy, Shahad Alanazi, Latifah Almohaimeed, Ghaida Alshamlani, Reham Alanazi, Khalid Alenezi
Publikováno v:
International Journal of Medicine in Developing Countries. :130-137
There has been a dramatic rise in the prevalence of atopic diseases in both developed and developing countries, especially children. Atopic dermatitis (AD), a specific form of eczema, is the most common chronic inflammatory skin disease. AD has signi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b28299597ba733c02fc684f574755ba4
https://doi.org/10.24911/ijmdc.51-1666594733
https://doi.org/10.24911/ijmdc.51-1666594733
Autor:
Hatan Mortada, Nawaf Alhindi, Abdulrahman Abukhudair, Shahad Alanazi, Alaa AlSahli, Khalid Arab
Publikováno v:
JPRAS open. 35
Glutamine (GLN) has been proven to improve the prognosis of severely burned patients. GLN supplementation in critical illness has gained extreme popularity among researchers over the years, and its safety and efficacy are still under question. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9f64053a412d569581d4dd37e0f2ef
https://pubmed.ncbi.nlm.nih.gov/36578449
https://pubmed.ncbi.nlm.nih.gov/36578449